SEC Form 4 · accession 0001103780-15-000072

Lexaria Bioscience Corp. · LXRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CEO · Director · 10% Owner

Period of report

Jan 20, 2010

Accepted (ET)

Dec 18, 2015 · 1:22 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001348362

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares^F1	Dec 16, 2015	A	448,896	—	A	4,937,854	I	Private holding company
Common Shares^F1	Dec 16, 2015	A	624,938	—	A	6,874,314	D
Common Shares	holding	—	—		—	4,488,958	I	Private holding company
Common Shares	holding	—	—		—	6,249,376	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options^F1,F2	$0.10	Dec 16, 2015	A	50,000	A	Dec 23, 2014	Dec 23, 2019	Common Shares	50,000	550,000	D
Stock Options^F1,F2	$0.32	Dec 16, 2015	A	20,000	A	Jul 11, 2011	Jul 11, 2016	Common Shares	20,000	770,000	D
Stock Options^F1,F2	$0.09	Dec 16, 2015	A	22,500	A	Jun 18, 2013	Jun 18, 2018	Common Shares	22,500	1,017,500	D
Warrants^F1,F2	$0.23	Dec 16, 2015	A	17,000	A	May 15, 2015	May 15, 2017	Common Shares	17,000	187,000	I
Stock Options^F2	$0.10	holding	—	—	—	Dec 23, 2014	Dec 23, 2019	Common Shares	500,000	500,000	D
Stock Options^F2	$0.32	holding	—	—	—	Jul 11, 2011	Jul 11, 2016	Common Shares	200,000	750,000	D
Stock Options^F2	$0.09	holding	—	—	—	Jun 18, 2013	Jun 18, 2018	Common Shares	225,000	995,000	D
Warrants^F2	$0.23	holding	—	—	—	May 15, 2015	May 15, 2017	Common Shares	170,000	170,000	I